A retrospective analysis of 24-month real-world glucose control for children and adolescents with type 1 diabetes using the MiniMed™ 670G insulin pump
(2022)
The MiniMed™ 670G insulin pump was the first hybrid closed-loop (HCL) system available for clinical use. Data on metabolic outcomes in children, adolescents and young adults over the first 12 months with auto-mode use of this device are available, but no data with longer follow-up have been published. We aimed to assess the metabolic outcomes in children and adolescents using the MiniMed™ 670G for 24 months.
Id prodotto:
132057
Handle IRIS:
11562/1085606
ultima modifica:
23 febbraio 2023
Citazione bibliografica:
Delvecchio, Maurizio; Galati, Alessio; Maffeis, Claudio; Passanisi, Stefano; Bonfanti, Riccardo; Franceschi, Roberto; Tornese, Gianluca; Calzi, Elena; Zanfardino, Angela; Bracciolini, Giulia Patrizia; Piccinno, Elvira,
A retrospective analysis of 24-month real-world glucose control for children and adolescents with type 1 diabetes using the MiniMed™ 670G insulin pump«DIABETES, OBESITY AND METABOLISM»
, 2022
, pp. 1-5